Anixa Biosciences
ANIX
16 hedge funds and large institutions have $4.45M invested in Anixa Biosciences in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.27% less ownership
Funds ownership: 6.38% → 6.1% (-0.27%)
6% less funds holding
Funds holding: 17 → 16 (-1)
21% less capital invested
Capital invested by funds: $5.66M → $4.45M (-$1.21M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$126K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$114K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$42.4K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$32.6K |
| 5 |
JP Morgan Chase
New York
|
+$23.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$459K |
| 2 |
Morgan Stanley
New York
|
-$13.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.34K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$2K |
| 5 |
Bank of New York Mellon
New York
|
-$207 |
ANIX Hedge Fund Activity: Q2 2019 in Review
16 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q2 2019, worth a combined $4.45M — down 21% from $5.66M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ANIX and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 5 added.
The largest buyer was BlackRock, adding an estimated $126K. The largest seller was SG Americas Securities, exiting entirely with an estimated $459K sold.
- 16 institutional investors held Anixa Biosciences (ANIX) as of Q2 2019, down from 17 in Q1 2019.
- Funds reported $4.45M of Anixa Biosciences stock for Q2 2019, down 21% quarter-over-quarter.
- 2 funds opened new Anixa Biosciences positions in Q2 2019 and 3 closed out, a net change of -1 holder.
- The largest Anixa Biosciences buyer in Q2 2019 was BlackRock, an estimated $126K added.
- The largest Anixa Biosciences seller in Q2 2019 was SG Americas Securities, an estimated $459K sold.
Based on aggregated 13F filings for Q2 2019.